Whole exome sequencing identifies frequent somatic mutations in cell-cell adhesion genes in Chinese patients with lung squamous cell carcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Chenguang ^a,b,k   Gao, Zhibo ^c   Li, Fei ^d   Li, Xiangchun ^c,j   Sun, Yihua ^a,b   Wang, Mengyun ^a,b   Li, Dan ^c   Wang, Rui ^a,b   Li, Fuming ^d   Fang, Rong ^d   Pan, Yunjian ^a,b   Luo, Xiaoyang ^a,b   He, Jing ^a,b   Zheng, Liangtao ^c   Xia, Jufeng ^d   Qiu, Lixin ^a,b   He, Jun ^c   Ye, Ting ^a,b   Zhang, Ruoxin ^a,b   He, Minghui ^c   Zhu, Meiling ^a,b   Hu, Haichuan ^a,b   Shi, Tingyan ^a,b   Zhou, Xiaoyan ^a,b   Sun, Menghong ^a,b   Tian, Shilin ^c   Zhou, Yong ^c   Wang, Qiaoxiu ^c   Chen, Longyun ^c   Yin, Guangliang ^c   Lu, Jingya ^c   Wu, Renhua ^c   Guo, Guangwu ^c   Li, Yingrui ^c   Hu, Xueda ^c   Li, Lin ^c   Asan, ^c   Wang, Qin ^c   Yin, Ye ^c   Feng, Qiang ^c   Wang, Bin ^c   Wang, Hang ^c   Wang, Mingbang ^c   Yang, Xiaonan ^a,c   Zhang, Xiuqing ^c   Yang, Huanming ^c   Jin, Li ^b   Wang, Cun Yu ^e   Ji, Hongbin ^d   Chen, Haiquan ^a,b   Wang, Jun ^c,g,h,i   Wei, Qingyi ^a,f   more..

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c BGI SHENZHEN   (China)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g University of Copenhagen   (Denmark)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ BGI Shanghai Eastern China BGI Shenzhen   (China)

^j CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^k TIANJIN MEDICAL UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CHINA; EXOME; GENETICS; HUMAN; LUNG TUMOR; MUTATION; PATHOLOGY; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CHINA; EXOME; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MUTATION; SEQUENCE ANALYSIS;

EID: 84946067461     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14237     Document Type: Article

References (49)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011
2. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J Clin 60, 277-300 (2010
3. Maemondo, M. et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362, 2380-2388 (2010
4. Gao, W. M. et al. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types. Lung Cancer 40, 141-150 (2003
5. Faoro, L. et al. EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. The Journal of biological chemistry 285, 18575-18585 (2010
6. Sasaki, H. et al. NFE2L2 gene mutation in male Japanese squamous cell carcinoma of the lung. J Thorac Oncol 5, 786-789 (2010
7. Viglietto, G. Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle 8, 2869-2870 (2009
8. Strazisar, M., Mlakar, V., Rott, T. & Glavac, D. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma. Cancer Invest 27, 407-416 (2009
9. Lee, J. W. et al. ERBB2 kinase domain mutation in the lung squamous cell carcinoma. Cancer Lett 237, 89-94 (2006
10. Bass, A. J. et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41, 1238-1242 (2009
11. Weiss, J. et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2, 62ra93 (2010
12. Ramos, A. H. et al. Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer Biol Ther 8, 2042-2050 (2009
13. Hammerman, P. S. et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature, 489, 519-525 (2012
14. Kim, Y. et al. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East asian patients. J Clin Oncol 32, 121-128 (2014
15. Pfeifer, G. P. et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-Associated cancers. Oncogene 21, 7435-7451 (2002
16. Williams, M. J., Lowrie, M. B., Bennett, J. P., Firth, J. A., Clark, P. Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse. Brain research 1058, 62-72 (2005
17. Shimmyo, T. et al. Etiologic value of p53 mutation spectra and differences with histology in lung cancers. Cancer Sci 99, 287-295 (2008
18. Fujita, T., Kiyama, M., Tomizawa, Y., Kohno, T. & Yokota, J. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol 15, 927-934 (1999
19. Singh, A. et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 3, e420 (2006
20. Kim, Y. R. et al. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol 220, 446-451 (2010
21. Ahn, J. W. et al. Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers. Genome medicine 6, 18 (2014
22. Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339 (2013
23. Kools, P., Vanhalst, K., Van den Eynde, E. & van Roy, F. The human cadherin-10 gene: complete coding sequence, predominant expression in the brain, and mapping on chromosome 5p13-14. FEBS Lett 452, 328-334 (1999
24. Taguchi, K., Motohashi, H. & Yamamoto, M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123-140 (2011
25. Solis, L. M. et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res 16, 3743-3753 (2010
26. Kobayashi, A. et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 26, 221-229 (2006
27. Ding, L. et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075 (2008
28. Gonzalez-Perez, A., Jene-Sanz, A. & Lopez-Bigas, N. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples. Genome biology 14, r106 (2013
29. Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542 (2011
30. Gui, Y. et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43, 875-878 (2011
31. Le Gallo, M. et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatinremodeling and ubiquitin ligase complex genes. Nat Genet 44, 1310-1315 (2012
32. Mamo, A. et al. An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. Oncogene 31, 2090-2100 (2012
33. Liu, P. et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis 33, 1270-1276 (2012
34. Thiagalingam, S. et al. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol 14, 65-72 (2002
35. Cox, C. et al. A survey of homozygous deletions in human cancer genomes. Proc Natl Acad Sci USA 102, 4542-4547 (2005
36. Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157 (2011
37. Conacci-Sorrell, M., Zhurinsky, J. & Ben-Ze'ev, A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109, 987-991 (2002
38. Schlegelmilch, K. et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144, 782-795 (2011
39. Berx, G., Nollet, F. & van Roy, F. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun 6, 171-184 (1998
40. Kim, N. G., Koh, E., Chen, X., Gumbiner, B. M. E-cadherin mediates contact inhibition of proliferation through Hippo signalingpathway components. Proc Natl Acad Sci USA 108, 11930-11935 (2011
41. Zhao, B., Tumaneng, K. & Guan, K. L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13, 877-883 (2011
42. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009
43. Picard-tools. http://picard.sourceforge.net, (2011) (Date of access: 23/06/2012
44. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20, 1297-1303 (2010
45. Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22, 568-576 (2012
46. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38, e164 (2010
47. Gui, Y. et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43, 875-878 (2011
48. Ji, H. et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807-810 (2007
49. Ji, H. et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 25, 2105-2112 (2006